- Tytuł:
- Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial.
- Autorzy:
- Źródło:
- Cancer medicine [Cancer Med] 2022 Jan; Vol. 11 (1), pp. 61-73. Date of Electronic Publication: 2021 Nov 17.
- Typ publikacji:
- Clinical Trial, Phase II; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Adenine/*analogs & derivatives
Antineoplastic Agents/*therapeutic use
Lymphoma, Follicular/*drug therapy
Lymphoma, Follicular/*genetics
Piperidines/*therapeutic use
Adenine/therapeutic use ; CARD Signaling Adaptor Proteins/genetics ; DNA-Binding Proteins/genetics ; Genetic Markers ; Guanylate Cyclase/genetics ; Humans ; Mutation ; Recurrence ; Exome Sequencing
Czasopismo naukowe